Skip to main content

Advertisement

Advertisement

World

3 health workers who received AstraZeneca COVID-19 vaccine in hospital with 'unusual' symptoms, Norway says

3 health workers who received AstraZeneca COVID-19 vaccine in hospital with 'unusual' symptoms, Norway says

FILE PHOTO: A vial of AstraZeneca coronavirus vaccine is seen at a vaccination centre in Westfield Stratford City shopping centre, in London, on Feb 18, 2021. (Photo: REUTERS/Henry Nicholls)

OSLO: Three health workers in Norway who recently received the AstraZeneca vaccine against COVID-19 are being treated in hospital for bleeding, blood clots and a low count of blood platelets, Norwegian health authorities said on Saturday (Mar 13).

Norway halted on Thursday the roll-out of that vaccine, following a similar move by Denmark. Iceland later followed suit.

"We do not know if the cases are linked to the vaccine," Sigurd Hortemo, a senior doctor at the Norwegian Medicines Agency told a news conference held jointly with the Norwegian Institute of Public Health.

All three individuals were under the age of 50.

READ: AstraZeneca's lower EU vaccine supply target hinges on factory approval: Source

READ: No reason to stop using AstraZeneca COVID-19 vaccine: WHO

The European medicine regulator EMA would investigate the three incidents, Hortemo added.

"They have very unusual symptoms: bleeding, blood clots and a low count of blood platelets," Steinar Madsen, Medical Director at the Norwegian Medicines Agency told broadcaster NRK.

"They are quite sick ... We take this very seriously," he said, adding authorities had received notification of the cases on Saturday.

AstraZeneca was not immediately available for comment.

Before Denmark's and Norway's move, Austria stopped using a batch of AstraZeneca shots while investigating a death from coagulation disorders and an illness from a pulmonary embolism.

READ: Australia continues AstraZeneca roll-out, says no evidence of blood clots

READ: Denmark, Norway temporarily suspend AstraZeneca COVID shots after blood clot reports

Still, EMA on Thursday said the vaccine's benefits outweighed its risks and could continue to be administered.

Europe is struggling to speed up a vaccine roll-out after delivery delays from Pfizer and AstraZeneca, even as a spike in cases amid a more contagious virus variant has triggered fresh lockdowns in countries like Italy and France.

BOOKMARK THIS: Our comprehensive coverage of the coronavirus outbreak and its developments

Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram

Source: Reuters/ga

Advertisement

Also worth reading

Advertisement